[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].

OBJECTIVE To study the clinical efficacy and safety of lamivudine in the treatment of chronic hepatitis B. METHODS 72 patients with hepatitis B were randomly assigned into lamivudine (n = 54) and placebo groups (n = 18) for 12 weeks. Then, all the patients received lamivudine 100 mg daily until week 104. Clinical symptoms, liver function tests, serum HBV… CONTINUE READING